Buy new:
-
Ships from: YnsSeller Sold by: YnsSeller
Save with Used - Like New
-
Ships from: ThriftBooks-Baltimore Sold by: ThriftBooks-Baltimore
Download the free Kindle app and start reading Kindle books instantly on your smartphone, tablet, or computer - no Kindle device required.
Read instantly on your browser with Kindle for Web.
Using your mobile phone camera - scan the code below and download the Kindle app.
Follow the authors
OK
Juvenescence: Investing in the Age of Longevity Paperback – September 25, 2017
Purchase options and add-ons
- Print length437 pages
- LanguageEnglish
- PublisherFruitful Pubns
- Publication dateSeptember 25, 2017
- Dimensions6 x 1.25 x 8.25 inches
- ISBN-100993047815
- ISBN-13978-0993047817
Book recommendations, author interviews, editors' picks, and more. Read it now.
Customers who bought this item also bought
Product details
- Publisher : Fruitful Pubns
- Publication date : September 25, 2017
- Edition : 1st
- Language : English
- Print length : 437 pages
- ISBN-10 : 0993047815
- ISBN-13 : 978-0993047817
- Item Weight : 1.75 pounds
- Dimensions : 6 x 1.25 x 8.25 inches
- Best Sellers Rank: #1,567,002 in Books (See Top 100 in Books)
- #1,467 in Stock Market Investing (Books)
About the authors

Jim Mellon is a British entrepreneur, investor and philanthropist with a wide range of interests. Through his private investment company, Burnbrae Group, he has substantial real estate holdings in Germany, as well as strategic holdings in private and public companies listed around the world.
Jim has authored a number of books including "Juvenescence – Investing in the Age of Longevity" which marked the beginning of a rush of capital into the nascent field of ageing research. This also led to the formation of the company Juvenescence with his long standing partners. Juvenescence is a leading biopharma company involved in the commercialisation of therapies to slow, stop and reverse ageing.
More recently Jim authored the book "Moo’s Law" focusing on investment opportunities in the field of cellular agriculture - the production of proteins and materials directly from cells. Jim co-founded Agronomics, a London listed company which invests in a portfolio of leading companies in this sector and he is its largest investor.
Jim sits on the Board of Trustees of the Buck Institute for Research on Aging, and of the American Federation for Aging Research (AFAR). He is also an Honorary Fellow of Oriel College at the University of Oxford, where he has established the Mellon Centre for Longevity. Jim is on the Advisory Board of the Milken Institute’s Centre for the Future of Aging and is a Trustee and co-founder of The Longevity Forum. Jim is one of the Founding Members of The Longevity Biotechnology Association which was launched during Longevity Week 2021.

Al Chalabi is an entrepreneur and business advisor with an impressive track record in a range of industries.
He grew up in the UK and studied Aeronautical Engineering at the University of Southampton. Al started his professional career in Canada, working as an engineer in process automation systems. After obtaining his MBA, he worked as a management consultant, specialising in technology, strategy and operations, and has been based out of Hong Kong ever since.
Since 2008, Al has been running CASP-R, a firm he founded to provide independent research and advisory services to investors and corporations, with a focus on real estate and technology. He is active in various Hong Kong-based angel investor groups that provide seed funding to Asian-based tech and healthcare companies. Al has been writing books with Jim since they first joined forces to write Wake Up! Survive and Prosper in the Coming Economic Turmoil, published at the end of 2005 (Wiley).
Al lives in Hong Kong with his partner Fiona and two children, Enzo and Margaux.


